M&A Deal Summary

Caidya Acquires Choice Pharma

On March 11, 2014, Caidya acquired life science company Choice Pharma

Acquisition Highlights
  • This is Caidya’s 5th transaction in the Life Science sector.
  • This is Caidya’s 1st transaction in Taiwan.

M&A Deal Summary

Date 2014-03-11
Target Choice Pharma
Sector Life Science
Buyer(s) Caidya
Deal Type Add-on Acquisition

Target

Choice Pharma

Taipei, Taiwan
Choice Pharma is a contract research organization based in Asia-Pacific. Our extensive experience covers virtually every therapeutic area and runs from first-into-human studies to phase IV and beyond.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Caidya

Morrisville, North Carolina, United States

Category Company
Founded 2003
Sector Life Science
DESCRIPTION

Caidya offers a wide range of clinical services and vast therapeutic expertise, supporting its partners from pre-IND strategy, through clinical development to submission and post-marketing surveillance. Caidya is a proprietary clinical technology to ensure trial transparency and data-driven decision-making. Caidya was founded in 2003 and is based in Morrisville, North Carolina.


DEAL STATS #
Overall 5 of 7
Sector: Life Science M&A 5 of 7
Type: Add-on Acquisition M&A Deals 5 of 6
Country: Taiwan M&A 1 of 1
Year: 2014 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2012-09-25 Paragon Biomedical

Irvine, California, United States

Paragon Biomedical, Inc. is a full-service contract research organization (CRO). Paragon is an ideal partner to achieve our common long-term goals to drive innovation in clinical research through a technology-amplified service platform.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2015-04-13 Accovion

Eschborn, Germany

Accovion GmbH is a provider of clinical research services to the pharmaceutical, biotechnology and medical device industries.

Buy -